Furthermore, considering that IBD is a clinical condition characterized by a pro-inflammatory milieu, lactoferrin-dependent downregulation of inflammatory cytokines, such as IL6, IL8, and TNFα, as demonstrated both in in vitro and ex vivo models, could represent a beneficial approach in disease management [2,54]. The gene discussed is LTF; the disease is irritable bowel syndrome.